Drug Trial Radar · NCT07052006
A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
37
Actual
Start
Dec 9, 2023
Primary completion
Jan 8, 2026
Study completion Sep 30, 2026
Sponsor
- Lead sponsor
- Halia Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This research is being conducted to asses if HT-6184 is effective in the treatment of Very Low, Low, or Intermediate Risk Myelodysplastic Syndrome (MDS) and Symptomatic Anemia. The study includes a 28-day Screening Period followed by a 16- or 32-week Treatment Period. Participants will be monitored at each cycle for drug tolerance, safety, and hematological response. A response assessment will occur after 16 weeks of study treatment.
Conditions
- Myelodysplastic Syndrome
- Anemia in Myelodysplastic Syndromes
Interventions
HT-6184Drug
Oral HT-6184
Primary outcomes
What the sponsor says the trial is designed to measure.
- The rate of hematological improvement.Time frame: 16 weeks
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Hemato Oncology Clinica Ahmedabad Pvt. Ltd. Vedanta Institute of Medical Sciences
Ahmedabad, Gujarat, India
Shalby Hospital
Ahmedabad, Gujarat, India
Malabar Cancer Center
Kannur, Kerala, India
HCG Cancer Center Vizag
Visakhapatnam, Krishna, India
Dr. Bafna's Star Superspeciality Clinic and Hospital
Kolhāpur, Maharashtra, India
All India Institute of Medical Sciences
Dehradun, Rishkesh, India
Meenakshi Mission Hospital and Research Centre
Madurai, Tamil Nadu, India
Apollo Cancer Centre
Hyderabad, Telangana, India
Nil Ratan Sircar Medical College and Hospital
Kolkata, West Bengal, India
Tata Medical Center
Kolkata, West Bengal, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.